KRAS and cancer: Accordingly, the HMH genomic DNA mixture was determined to carry 24.1% KRAS c.35G > T, 10.1% BRAF c.1391G > T, and 24.1% BRAF c.1799T > A. The values are consistent with the theoretical value calculated from the gene mutation genotypes of the three cancer cell lines.